Chinese Journal of Organic Chemistry ›› 2024, Vol. 44 ›› Issue (11): 3550-3555.DOI: 10.6023/cjoc202403009 Previous Articles     Next Articles

NOTE

选择性雌激素受体降解剂(S)-8-(4-(1-(3-氟丙基)吡咯烷-3-基)氧基)苯基)-7-(4-羟基苯基)-5,6-二氢萘-2-醇的汇聚合成

陈盼盼a, 冯晓伟a, 陆智彭b, 厉廷有a,b,*()   

  1. a 南京医科大学药学院 核药学系 南京 211166
    b 南京医科大学药学院 药物化学系 南京 211166
  • 收稿日期:2024-03-06 修回日期:2024-05-21 发布日期:2024-06-24
  • 基金资助:
    南京医科大学科技发展基金(NMUB20210013); 南京医科大学内涵建设重点项目; 中国博士后科学基金(2022M711419); 及江苏省自然科学基金(BK20231266)

Convergent Strategy to Synthesize (S)-8-(4-((1-(3-Fluoropropyl)-pyrrolidin-3-yl)oxy)phenyl)-7-(4-hydroxyphenyl)-5,6-dihydronaphthalen-2-ol as a Selective Estrogen Receptor Degrader

Panpan Chena, Xiaowei Fenga, Zhipeng Lub, Tingyou Lia,b,*()   

  1. a Department of Radiopharmaceuticals, School of Pharmacy, Nanjing Medical University, Nanjing 211166
    b Department of Medicinal Chemistry, School of Pharmacy, Nanjing Medical University, Nanjing 211166
  • Received:2024-03-06 Revised:2024-05-21 Published:2024-06-24
  • Contact: *E-mail:l_tingyou@njmu.edu.cn
  • Supported by:
    Science and Technology Development Foundation of Nanjing Medical University(NMUB20210013); Key Project of Connotation Construction of Nanjing Medical University; China Postdoctoral Science Foundation(2022M711419); Natural Science Foundation of Jiangsu Province(BK20231266)

A more feasibly convergent synthesis of selective estrogen receptor degrading agent (S)-8-(4-((1-(3-fluoropropyl)- pyrrolidin-3-yl)oxy)phenyl)-7-(4-hydroxyphenyl)-5,6-dihydronaphthalen-2-ol was reported, featured with concise work up and absence of regioselectivity dilemma.

Key words: breast cancer, selective estrogen receptor degrading agent, (S)-8-(4-((1-(3-fluoropropyl)pyrrolidin-3-yl)oxy)- phenyl)-7-(4 -hydroxyphenyl)-5,6-dihydronaphthalen-2-ol, improvement of synthesis